Par Drugs & Chemicals Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Mar'26

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Mar 2026 is -33.16% vs 2.37% in Dec 2025

Standalone Net Profit

QoQ Growth in quarter ended Mar 2026 is -82.29% vs 16.22% in Dec 2025

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is -76.24% vs -0.16% in Dec 2025

Interest

QoQ Growth in quarter ended Mar 2026 is 300.00% vs -80.00% in Dec 2025

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

Compare Quarterly Results Of Par Drugs & Che. With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

19.61

253.06

-233.45

-92.25%

Other Operating Income

0.00

Total Operating income

19.61

253.06

-233.45

-92.25%

Raw Material Cost

8.85

234.13

-225.28

-96.22%

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.06

-26.07

26.13

100.23%

Employee Cost

1.94

8.99

-7.05

-78.42%

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

7.32

32.24

-24.92

-77.30%

Total Expenditure (Excl Depreciation)

18.17

249.29

-231.12

-92.71%

Operating Profit (PBDIT) excl Other Income

1.44

3.77

-2.33

-61.80%

Other Income

0.36

0.57

-0.21

-36.84%

Operating Profit (PBDIT)

1.80

4.34

-2.54

-58.53%

Interest

0.04

0.00

0.04

Exceptional Items

0.00

Gross Profit (PBDT)

1.76

4.34

-2.58

-59.45%

Depreciation

0.93

1.44

-0.51

-35.42%

Profit Before Tax

0.83

2.91

-2.08

-71.48%

Tax

-0.02

0.73

-0.75

-102.74%

Provisions and contingencies

0.00

Profit After Tax

0.85

2.17

-1.32

-60.83%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

0.85

2.17

-1.32

-60.83%

Equity Capital

12.30

8.88

3.42

38.51%

Face Value

10.00

0.00

Reserves

99.68

0.00

99.68

Earnings per share (EPS)

0.69

2.44

-1.75

-71.72%

Diluted Earnings per share

0.69

2.45

-1.76

-71.84%

Operating Profit Margin (Excl OI)

7.34%

1.49%

0.00

5.85%

Gross Profit Margin

8.98%

1.72%

0.00

7.26%

PAT Margin

4.33%

0.86%

0.00

3.47%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 19.61 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is -33.16% vs 2.37% in Dec 2025

YoY Growth in quarter ended Mar 2026 is -12.18% vs -2.15% in Mar 2025

Quarterly - Standalone Net Profit

Standalone Net Profit 0.85 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is -82.29% vs 16.22% in Dec 2025

YoY Growth in quarter ended Mar 2026 is -48.48% vs -55.65% in Mar 2025

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 1.44 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is -76.24% vs -0.16% in Dec 2025

YoY Growth in quarter ended Mar 2026 is -40.74% vs -60.10% in Mar 2025

Quarterly - Interest

Interest 0.04 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is 300.00% vs -80.00% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 100.00% vs -60.00% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 7.34%

in Mar 2026

Figures in %

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025